Pulnovo Medical, a pioneer in breakthrough therapies for treating Pulmonary Hypertension and Heart Failure, today announced the successful completion of an oversubscribed $100 million strategic ...

Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...

Wearable device data may help detect and track idiopathic pulmonary arterial hypertension, a rare lung disease, a study ...

Allrock Bio has dosed the first participants in a small clinical trial testing ROC-101 as an add-on treatment for pulmonary ...

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva,” the “Company” “we” or “us”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the ...

Statesman. The health beat takes her inside operating rooms, laboratories and clinics to tell the story of health care from a ...

A wireless implantable device that remotely monitors pulmonary artery pressure offers reliable safety and is linked to a significant reduction in the risk for heart failure-related hospitalisation.

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

SPECT lung scans show low clot risk at three months, suggesting a potential alternative to CT in pulmonary embolism diagnosis ...

Country and blues singer Nat Myers provided his fans with an update on his battle against cancer this week. Myers has been ...

Background Acute pulmonary embolism (PE) mortality is linked to abrupt rises in pulmonary artery (PA) pressure due to mechanical obstruction and pulmonary vasoconstriction, leading to right ...

New findings reveal pulmonary arterial hypertension may affect the brain early. Learn how inflammation and cognitive decline ...